Ondansetron Injection — Class II drug recall D-013-2014
Terminated recall by Hospira Inc., reported 2013-11-27, distributed nationwide. Presence of Particular Matter: Potential vendor glass issue - glass spiticules (glass strands) were identified
| Recall number | D-013-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2013-09-24 |
| Classified | 2013-11-20 |
| Reported by FDA | 2013-11-27 |
| Terminated | 2014-10-06 |
| Distributed | Nationwide (US) |
| Quantity | 681,400 vials |
| Reason classes | foreign material |
| NDC | 00409-4755, 00409-4755-03, 00409-4755-18, 00409-4759, 00409-4759-01 |
| Expiration dates | 2015-05-01 |
Product
Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL Single-dose Vial, Rx Only, Sterile, Hospira Inc., Lake Forest IL 60045, USA, NDC 0409-4755-03
Reason for recall
Presence of Particular Matter: Potential vendor glass issue - glass spiticules (glass strands) were identified during site inspection of the vials.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-013-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.